Literature DB >> 18560226

Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.

Meltem Demirel Kars1, Ozlem Darcansoy Işeri, Ufuk Gunduz, Jozsef Molnar.   

Abstract

BACKGROUND: Ineffectiveness of anticancer drugs is frequently observed in cancer chemotherapy. The resistance of tumor cells to various cytotoxic drugs is defined as multidrug resistance (MDR). The purpose of this study is to investigate the potential reversal effect of some synthetic and natural chemicals on drug-resistant MCF-7 cell lines. The effects of potential MDR modulators combined with some anticancer drugs were also studied.
METHODS: Flow cytometry, MTT cytotoxicity assays and checkerboard combination assays were performed to study the reversal of drug resistance and to investigate the antiproliferative effects of the combination of anticancer drugs and the potential modulators. The results indicated that verapamil, capsanthin, zeaxanthin and promethazine inhibited P-gp effectively, but chrysin was not effective at reversing the resistance in MCF-7 sublines. Four selective anticancer drugs (paclitaxel, docetaxel, doxorubicin and vincristine) and 4 effective MDR modulators (verapamil, capsanthin, zeaxanthin and promethazine) were applied to the sublines in combination. RESULTS AND
CONCLUSION: Fractional inhibitory indices show that verapamil and zeaxanthin seem to be the most effective MDR reversal agents that may be used together with paclitaxel, docetaxel, vincristine and doxorubicin in drug-resistant mammary carcinoma sublines. In conclusion, this report represents the importance to find out active and efficient drug resistance modulators for improving the efficacy of chemotherapy. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560226     DOI: 10.1159/000140462

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  18 in total

1.  Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium.

Authors:  Cody P Coyne; Toni Jones; Andrzej Sygula; John Bailey; Lesya Pinchuk
Journal:  J Cancer Ther       Date:  2011-03

2.  Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione.

Authors:  Heather M Brechbuhl; Remy Kachadourian; Elysia Min; Daniel Chan; Brian J Day
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-10       Impact factor: 4.219

3.  Exploring a natural MDR reversal agent: potential of medicinal food supplement Nerium oleander leaf distillate.

Authors:  Meltem Demirel Kars; Ufuk Gündüz; Kamil Uney; Ahmet Levent Baş
Journal:  Asian Pac J Trop Biomed       Date:  2013-08

4.  Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.

Authors:  Cody P Coyne; Toni Jones; Ryan Bear
Journal:  Cancer Biother Radiopharm       Date:  2011-12-22       Impact factor: 3.099

5.  Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells.

Authors:  Ting Zhou; Jingjing Duan; Yan Wang; Xin Chen; Ganping Zhou; Rongkan Wang; Liwu Fu; Feng Xu
Journal:  Tumour Biol       Date:  2012-05-02

6.  Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma.

Authors:  C P Coyne; Toni Jones; Ryan Bear
Journal:  J Clin Exp Oncol       Date:  2013

7.  Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative Tubulin/Microtubule Inhibitors on the Cytotoxic Anti-Neoplastic Potency of Epirubicin-(C3-amide)-Anti-HER2/neu Synthesized Utilizing a UV-Photoactivated Anthracycline Intermediate.

Authors:  C P Coyne; Toni Jones; Ryan Bear
Journal:  Cancer Clin Oncol       Date:  2012-11

8.  Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3.

Authors:  Cody P Coyne; Toni Jones; Ryan Bear
Journal:  J Cancer Ther       Date:  2012-10

9.  A therapeutic keypad lock decoded in drug resistant cancer cells.

Authors:  Gulsen Turkoglu; Gozde Kayadibi Koygun; Mediha Nur Zafer Yurt; Seyda Nur Pirencioglu; Sundus Erbas-Cakmak
Journal:  Chem Sci       Date:  2021-06-17       Impact factor: 9.825

10.  Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity.

Authors:  Timothy A McCaffrey; Constantine Tziros; Jannet Lewis; Richard Katz; Robert Siegel; William Weglicki; Jay Kramer; I Tong Mak; Ian Toma; Liang Chen; Elizabeth Benas; Alexander Lowitt; Shruti Rao; Linda Witkin; Yi Lian; Yinglei Lai; Zhaoqing Yang; Sidney W Fu
Journal:  Int J Biol Sci       Date:  2013-04-22       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.